• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • Drug Policy and Law
  • Harm Reduction
  • Activism

Drugreporter

News and Films from the Frontline of the War on Drugs

  • News
  • Café
  • Videos
  • About Us
  • EN
    • HU
    • RU

Civil Society Expresses Concerns Over EU Action Plan on Drugs

June 28, 2013 | Author: Péter Sárosi

Tweet

The EU’s expert group on drugs has discussed how civil society can be involved in a more meaningful way in the formulation of drug policy

The Civil Society Forum on Drugs is an expert group of the European Commission. It serves as a platform for dialogue between the EC and civil society. In 2013, 40 NGOs (including our own Drug Policy Program) were selected to be members of the Forum for a two-year period. A rich diversity of groups are represented at the Forum, covering most regions, professional fields and ideological approaches. Some NGOs focus on harm reduction, others on primary prevention. There are representatives of drug user communities and those who self-identify as recovered addicts. There are members who support drug prohibition, while others speak out for drug regulation. This diversity gives the Forum an advantage, because it enables it to express the complexity of the drug phenomenon. However, when it comes to decisions, the same diversity makes it extremely difficult to reach a consensus within the group on many issues. Even so, the Forum last year adopted a consensus document with a number of key recommendations. Those recommendations were presented to the government delegates at the Horizontal Drug Group (HDG).

We hoped that our recommendations would contribute to the development of the new Action Plan on Drugs (2013-16), which translates the longer-term aims of the EU Drug Strategy (2013-20) into short-term action. Unfortunately most of the Forum’s recommendations have not been incorporated into the final text. This, at any rate, was the general feeling among those civil society representatives who attended the annual meeting of the Forum in Brussels this week.

Many members of the expert group (inlcuding the outgoing chair, Eberhard Schatz) expressed their concern about the document’s failure to adequately cover, and give clear indicators in regard to, harm reduction inteventions. Harm reduction objectives are subordinated to treatment and recovery objectives. This is a step back from the political commitment of the previous Action Plan, which had more specific objectives and indicators to ensure that harm reduction programs are scaled up. For instance, the previous Action Plan had specific objectives to scale up opiate substitution treatment in prisons – this is missing from the current plan.

This is disturbing for many reasons. First, as we reported earlier (read our article!), external evaluation of the previous drug strategy concluded that there is only one policy area which can show clear indications of success: harm reduction. If the EU claims to base drug policies on evidence, why is harm reduction neglected?  Second, we are living in a time of financial austerity, where evidence-based, life-saving services are no longer fighting to be expanded, but struggling for sheer survival. Such programs are among the first victims of budget cuts, while the budget devoted to law-enforcement interventions of uncertain effectiveness continues to grow. Can we afford to spend a lot of money on unproven supply-reduction interventions, in the middle of a financial crisis? Third, and maybe most importantly, the impacts of the financial crisis are now very visible within Eastern member states of the EU: HIV epidemics have broken out among injecting drug users in two countries where prevalence had previously been low – Greece and Romania. Hepatitis C prevalence remains high among IDUs, and overdoses are still the major cause of death among this group. There is a growing demand for harm reduction interventions, due to an increase in injecting stimulant use, but access to such programs is very limited. We need an EU-wide political commitment and financial investment to tackle drug- and drug-policy-related harms, inlcuding needle and syringe programs, supervised injecting facilities, opiate substitution and overdose prevention training with Naloxone distribution.


Meeting of the old and new Core Group of the Civil Society Forum on Drugs

The Forum elected five people to the new core group this week, with Raminta Stuikyte (EATG) as chair and Fay Watson (European Cities Against Drugs) as co-chair. There are three other members of the core group who chair the three working groups of the Forum: on the quality standards for demand reduction (Matej Kosir, Institute for Research and Development), on UNGASS 2016 (Maria Phelan, European Harm Reduction Network) and on co-ordination with the Horizontal Drug Group of EU member states (myself).

We are in a fortunate position, in that there are very open-minded people at the Drug Unit of the European Commission, who support the involvement of civil society. On Tuesday, we had our first joint meeting with the government delegates to the HDG, where we discussed the Action Plan and possible future co-operation. The representatives of the outgoing Irish EU presidency assured us that civil society recommendations have been taken into consideration during the drafting of the new Action Plan; however, as they pointed out, the final text was a compromise and nobody was entirely happy with it. Now it is up to the new Lithuanian (and then Greek) EU presidency, to help us to give a voice to civil society in the implementation of the Action Plan.

Posted by Peter Sarosi

 

Filed Under: Articles Topics: Activism, Drug Policy and Law, Harm Reduction, New Psychoactive Substances, UN Drug policy

Access to this article is free - but to produce articles and videos is not. Drugreporter is a non-profit website that needs your support to provide you with high quality contents.

Become a supporter and make a donation of 5 $ today!

Kapcsolódó cikkek:

The Italian Anti-Rave Law Violates Human Rights – Interview with Susanna Ronconi

February 1, 2023 - Péter Sárosi

40 Years in the Frontlines of Harm Reduction in Ireland – Interview with Tony Duffin

December 20, 2022 - Péter Sárosi

Decriminalisation in Portugal: Through the Lens of People who Use Drugs

December 5, 2022 - István Gábor Takács

Kapcsolódó videók:

Decriminalisation in Portugal: Through the Lens of People who Use Drugs

December 5, 2022 - István Gábor Takács

Drugreporter News | 2022 November

November 24, 2022 - István Gábor Takács

Harm Reduction in Athens – With the Eye of an Outsider

November 23, 2022 - Péter Sárosi

You can browse our topics here:

Activism COVID-19 Criminalisation Dose of Science Drug Consumption Rooms Drug Policy and Law European Drug Policy Harm Reduction Hepatitis HIV/AIDS Marijuana Policies Medical Marijuana Needle and syringe programs New Psychoactive Substances Opiate Substitution Overdose Prevention Psychedelic Medicines Regulation and Control Russian Drug Policy Sex Work United Nations Drug Policy US Drug Policy

Primary Sidebar

BECOME A SUPPORTER OF DRUGREPORTER! INVEST THE PRICE OF A COFFEE MONTHLY AND MAKE SURE DRUGREPORTER KEEPS RUNNING!
Subscribe to the Newsletter!

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
  • Facebook
  • Twitter
  • YouTube

Search

Drugreporter Video Database

Hundreds of videos on drug policy, harm reduction and human rights for streaming and download, also on a world map!

DRUGREPORTER NEWS

Monthly drug policy news from around the world

Drugreporter café

In our new online video show, we regularly discuss new developments in the world of drug policy with professionals, activists and decision makers. You can also listen to the Drugreporter Café in Podcast format on Spotify or Apple Podcasts!

COVID-19 Harm Reduction Update

On this info page Drugreporter provides regular updates about resources and news on how harm reduction service providers respond to the COVID-19 Epidemic.

Drugreporter Video Advocacy Network

Browse videos produced by members of our Drugreporter Video Advocacy Network, from all around the world!

DRUG USERS NEWS

Russian language videos on drug policy, harm reduction and human rights.

Our award winning animated documentary movie is based on the original audio recording of Kostya Proletarsky, a drug user and HIV activist who died as a result of mistreatment and torture at a Russian prison. Festival appearances, news and resources are available here!

Footer

Rights Reporter Foundation
Hungary, 1032 Budapest
San Marco Street 70.
Email: rightsreporter@rightsreporter.net

Search

Our other websites:

The Rights Reporter Foundation

The Autocracy Analyst

Room for Change Campaign

Room in the 8th District Campaign

A Day in the Life movie website

Drugreporter